氟嘧啶与二氢嘧啶脱氢酶检测：真的存在必然联系吗？ - Suppr

Suppr

超能文献

Fluoropyrimidines and DPD testing: is there truly an inexorable link?

作者信息

Milano Gérard

机构信息

Oncopharmacology Unit, Centre Antoine Lacassagne, 33, Avenue de Valombrose - 061 89 Nice Cedex, France.

出版信息

Eur J Cancer. 2019 May;113:45-46. doi: 10.1016/j.ejca.2019.03.013. Epub 2019 Apr 8.

DOI:10.1016/j.ejca.2019.03.013

PMID:30974323

Abstract

摘要

相似文献

Fluoropyrimidines and DPD testing: is there truly an inexorable link?

Eur J Cancer. 2019 May;113:45-46. doi: 10.1016/j.ejca.2019.03.013. Epub 2019 Apr 8.

Safety Report of TAS-102 in a Patient With Reduced DPD Activity.

Clin Colorectal Cancer. 2019 Dec;18(4):310-312. doi: 10.1016/j.clcc.2019.07.008. Epub 2019 Jul 29.

Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity.

Br J Cancer. 2017 May 23;116(11):1415-1424. doi: 10.1038/bjc.2017.94. Epub 2017 Apr 20.

[5-fluorouracil and dihydropyrimidine dehydrogenase].

Gan To Kagaku Ryoho. 2001 Apr;28(4):433-9.

Predicting fluoropyrimidine-related toxicity: turning wish to will, the PAMM-EORTC position.

Ann Oncol. 2018 Sep 1;29(9):1893-1894. doi: 10.1093/annonc/mdy258.

Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio.

Clin Pharmacol Ther. 2016 Feb;99(2):235-42. doi: 10.1002/cpt.210. Epub 2015 Nov 10.

[Review of methods for determination of dihydropyrimidine dehydrogenase and possible application in screening previous chemotheraphy with 5-fluorouracil].

Przegl Lek. 2012;69(9):694-7.

Is uracil enough for effective pre-emptive DPD testing?

Clin Chem Lab Med. 2024 Jul 19;62(12):e255-e256. doi: 10.1515/cclm-2024-0742. Print 2024 Nov 26.

Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.

Gastric Cancer. 2003;6 Suppl 1:66-70. doi: 10.1007/s10120-003-0225-8.

The dihydrouracil/uracil ratio in plasma, clinical and genetic analysis for screening of dihydropyrimidine dehydrogenase deficiency in colorectal cancer patients treated with 5-fluorouracil.

Pathol Biol (Paris). 2009 Sep;57(6):470-6. doi: 10.1016/j.patbio.2008.05.001. Epub 2008 Jul 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Fluoropyrimidines and DPD testing: is there truly an inexorable link?

作者信息

Milano Gérard

机构信息

Oncopharmacology Unit, Centre Antoine Lacassagne, 33, Avenue de Valombrose - 061 89 Nice Cedex, France.

出版信息

Eur J Cancer. 2019 May;113:45-46. doi: 10.1016/j.ejca.2019.03.013. Epub 2019 Apr 8.

DOI:10.1016/j.ejca.2019.03.013

PMID:30974323

Abstract

摘要

相似文献

Fluoropyrimidines and DPD testing: is there truly an inexorable link?

Eur J Cancer. 2019 May;113:45-46. doi: 10.1016/j.ejca.2019.03.013. Epub 2019 Apr 8.

Safety Report of TAS-102 in a Patient With Reduced DPD Activity.

Clin Colorectal Cancer. 2019 Dec;18(4):310-312. doi: 10.1016/j.clcc.2019.07.008. Epub 2019 Jul 29.

Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity.

Br J Cancer. 2017 May 23;116(11):1415-1424. doi: 10.1038/bjc.2017.94. Epub 2017 Apr 20.

[5-fluorouracil and dihydropyrimidine dehydrogenase].

Gan To Kagaku Ryoho. 2001 Apr;28(4):433-9.

Predicting fluoropyrimidine-related toxicity: turning wish to will, the PAMM-EORTC position.

Ann Oncol. 2018 Sep 1;29(9):1893-1894. doi: 10.1093/annonc/mdy258.

Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio.

Clin Pharmacol Ther. 2016 Feb;99(2):235-42. doi: 10.1002/cpt.210. Epub 2015 Nov 10.

[Review of methods for determination of dihydropyrimidine dehydrogenase and possible application in screening previous chemotheraphy with 5-fluorouracil].

Przegl Lek. 2012;69(9):694-7.

Is uracil enough for effective pre-emptive DPD testing?

Clin Chem Lab Med. 2024 Jul 19;62(12):e255-e256. doi: 10.1515/cclm-2024-0742. Print 2024 Nov 26.

Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.

Gastric Cancer. 2003;6 Suppl 1:66-70. doi: 10.1007/s10120-003-0225-8.

The dihydrouracil/uracil ratio in plasma, clinical and genetic analysis for screening of dihydropyrimidine dehydrogenase deficiency in colorectal cancer patients treated with 5-fluorouracil.

Pathol Biol (Paris). 2009 Sep;57(6):470-6. doi: 10.1016/j.patbio.2008.05.001. Epub 2008 Jul 10.